CDMO Competitive Assessment in the USA and Europe

Comprehensive competitor assessment within the pharmaceutical CDMO sector in the US and Europe

Objective:

A European-based Contract Development and Manufacturing Organization (CDMO) client engaged DelveInsight to conduct a comprehensive competitor assessment within the pharmaceutical CDMO sector. The scope of the assessment encompassed a thorough analysis of active companies operating in this domain, focusing on key aspects such as distribution strategies, product offerings, product specifications, and strengths of each competitor.

Key Problems:

• Identification and analysis of active companies operating in the pharma CDMO space
• Evaluation of distribution strategies employed by these CDMO entities
• Comprehensive examination of the diverse product offerings within the pharmaceutical CDMO sector
• Detailed scrutiny of product specifications, including technical attributes, quality standards, and unique features
• Identification and analysis of the strengths of each CDMO competitor, considering factors such as technological capabilities, regulatory compliance, and industry partnerships
• CDMO Market Analysis & Forecast for US & Europe

Our Methodology:

• List of CDMOs Active in the European Region
• Robust Competitive Landscape Analysis
• Detailed Company Profiling
• Service Portfolio Analysis
• Therapeutic Area Involvement
• Manufacturing Capabilities
• Details of Market Outreach

Strategic Research Outcomes:

• The growing number of companies in drug development has led to a large surge of CDMO companies in Europe and the USA.
• Many companies provide a wide variety of services, out of which, preclinical study execution is the largest aspect.
• Many companies are also in the business of developing antibodies and cell therapy candidates, due to the vastness of research required. Protein manufacturing also captures a large segment where companies are involved in contract development and manufacturing.
• An estimate of the overall installed capacity for CDMOs shows that many organizations have good capacity and multiple sites from where they run operations. Herein, the European Market outshines the number of CMOs and CDMOs as well as the level of manufacturing output in the case of manufacturing and development.